What is Lifeloc Technologies Inc's earnings per share (EPS)?

Lifeloc Technologies Inc (LCTC) reported diluted earnings per share of $-0.90 for fiscal year 2025. This represents a -119.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Lifeloc Technologies Inc Financials

LCTC

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Lifeloc Technologies Inc (LCTC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LCTC FY2025 2026-05-14

Lifeloc’s current constraint is not product-level margin but cash tied in inventory and overhead spread over a small revenue base.

FY2025 widened the accounting loss while easing the cash drain: net loss moved to -$2.5M from -$1.1M. Operating cash outflow improved to -$499K from -$1.3M, so the reported loss and the cash reality diverged; that usually points to non-cash charges and working-capital release, not a business that suddenly consumed far more cash than the year before.

Gross margin stayed essentially flat at 40.4% and 40.3% in the last two years, so the business did not lose its basic product economics even as sales remained range-bound. The pressure is below gross profit: R&D and SG&A absorb too much of a revenue base that is still only about $9.0M, which keeps fixed costs from being covered consistently.

Liquidity looks stronger on paper than in cash, because the FY2025 current ratio of 5.1x sits alongside only $746K of cash. With $2.6M in inventory and modest leverage, working capital-not debt service-is the nearer operating constraint; converting stock on hand into sales matters more than finding additional borrowing.

Financial Health Signals

Financial Profile 38/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Lifeloc Technologies Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Lifeloc Technologies Inc has an operating margin of -13.6%, meaning the company retains $-14 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -16.5% the prior year.

Growth

Lifeloc Technologies Inc's revenue grew 5.7% year-over-year to $9.0M, a solid pace of expansion. This earns a growth score of 31/100.

Leverage

Lifeloc Technologies Inc carries a low D/E ratio of 0.26, meaning only $0.26 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 5.10, Lifeloc Technologies Inc holds $5.10 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

While Lifeloc Technologies Inc generated -$499K in operating cash flow, capex of $463K consumed most of it, leaving -$962K in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Lifeloc Technologies Inc generates a -60.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -16.9% the prior year.

Piotroski F-Score Weak

2/9

Lifeloc Technologies Inc passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.20x

For every $1 of reported earnings, Lifeloc Technologies Inc generates $0.20 in operating cash flow (-$499K OCF vs -$2.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-10.3x

Lifeloc Technologies Inc earns $-10.3 in operating income for every $1 of interest expense (-$1.2M vs $119K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$9.0M

YoY+5.7%

5Y CAGR+7.3%

10Y CAGR+0.2%

Lifeloc Technologies Inc generated $9.0M in revenue in fiscal year 2025. This represents an increase of 5.7% from the prior year.

EBITDA

-$787K

YoY+29.4%

Lifeloc Technologies Inc's EBITDA was -$787K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 29.4% from the prior year.

Net Income

-$2.5M

YoY-134.6%

Lifeloc Technologies Inc reported -$2.5M in net income in fiscal year 2025. This represents a decrease of 134.6% from the prior year.

EPS (Diluted)

$-0.90

YoY-119.5%

Lifeloc Technologies Inc earned $-0.90 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 119.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$962K

YoY+48.5%

Lifeloc Technologies Inc generated -$962K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 48.5% from the prior year.

Cash & Debt

$746K

YoY-40.0%

5Y CAGR-19.4%

10Y CAGR-13.6%

Lifeloc Technologies Inc held $746K in cash against $1.1M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+3.3%

5Y CAGR+2.3%

10Y CAGR+1.2%

Lifeloc Technologies Inc had 3M shares outstanding in fiscal year 2025. This represents an increase of 3.3% from the prior year.

Margins & Returns

Gross Margin

40.4%

YoY-0.0pp

5Y CAGR+6.0pp

10Y CAGR-9.5pp

Lifeloc Technologies Inc's gross margin was 40.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.0 percentage points from the prior year.

Operating Margin

-13.6%

YoY+2.9pp

5Y CAGR+4.5pp

10Y CAGR-18.6pp

Lifeloc Technologies Inc's operating margin was -13.6% in fiscal year 2025, reflecting core business profitability. This is up 2.9 percentage points from the prior year.

Net Margin

-27.4%

YoY-15.0pp

5Y CAGR-12.9pp

10Y CAGR-30.6pp

Lifeloc Technologies Inc's net profit margin was -27.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 15.0 percentage points from the prior year.

Return on Equity

-60.2%

YoY-43.3pp

5Y CAGR-44.6pp

10Y CAGR-65.4pp

Lifeloc Technologies Inc's ROE was -60.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 43.3 percentage points from the prior year.

Capital Allocation

R&D Spending

$2.2M

YoY-4.0%

5Y CAGR+16.4%

10Y CAGR+5.8%

Lifeloc Technologies Inc invested $2.2M in research and development in fiscal year 2025. This represents a decrease of 4.0% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$463K

YoY-14.3%

5Y CAGR+75.9%

10Y CAGR+1.4%

Lifeloc Technologies Inc invested $463K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 14.3% from the prior year.

LCTC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$9.0M+5.7%	$8.5M-8.5%	$9.3M+10.0%	$8.5M+20.2%	$7.1M+11.0%	$6.4M
Cost of Revenue	$5.4M+5.8%	$5.1M-3.7%	$5.3M-2.2%	$5.4M+35.4%	$4.0M-4.4%	$4.2M
Gross Profit	$3.6M+5.7%	$3.4M-14.7%	$4.0M+31.4%	$3.1M+0.5%	$3.1M+40.3%	$2.2M
R&D Expenses	$2.2M-4.0%	$2.2M+22.2%	$1.8M+32.4%	$1.4M+14.2%	$1.2M+20.5%	$1.0M
SG&A Expenses	$1.4M+10.8%	$1.3M+7.1%	$1.2M-3.8%	$1.2M+9.5%	$1.1M-11.4%	$1.3M
Operating Income	-$1.2M+12.7%	-$1.4M-636.8%	-$191K+70.6%	-$650K-141.8%	-$269K+76.7%	-$1.2M
Interest Expense	$119K+196.9%	$40K-3.4%	$42K-3.5%	$43K-16.0%	$51K-8.7%	$56K
Income Tax	$1.2M+428.8%	-$353K+4.3%	-$368K-214.8%	-$117K-107.8%	-$56K+79.6%	-$275K
Net Income	-$2.5M-134.6%	-$1.1M-612.1%	$206K+145.1%	-$456K-167.4%	$676K+173.3%	-$922K
EPS (Diluted)	$-0.90-119.5%	$-0.41-612.5%	$0.08+142.1%	$-0.19-170.4%	$0.27+171.1%	$-0.38

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$2.3M+0.9%	$2.3M+0.7%	$2.3M+1.7%	$2.2M-2.5%	$2.3M+19.2%	$1.9M-8.5%	$2.1M-12.6%	$2.4M
Cost of Revenue	$1.3M-4.7%	$1.4M+1.5%	$1.4M+4.3%	$1.3M-5.4%	$1.4M+13.6%	$1.2M+2.5%	$1.2M-15.7%	$1.4M
Gross Profit	$987K+9.4%	$902K-0.5%	$907K-1.9%	$925K+1.8%	$909K+28.8%	$705K-22.7%	$912K-8.2%	$994K
R&D Expenses	$414K-31.1%	$601K+31.0%	$459K-26.4%	$623K+32.7%	$470K-6.8%	$504K-3.3%	$521K-21.3%	$662K
SG&A Expenses	$387K+20.1%	$323K-5.3%	$341K+0.2%	$340K-11.6%	$385K+25.8%	$306K+13.5%	$269K-25.8%	$363K
Operating Income	-$128K+62.0%	-$337K-43.8%	-$234K+38.1%	-$378K-34.8%	-$281K+33.6%	-$423K-102.9%	-$208K+47.5%	-$397K
Interest Expense	$31K-0.6%	$31K-14.9%	$37K+40.5%	$26K+7.4%	$24K+147.0%	$10K-1.0%	$10K-0.4%	$10K
Income Tax	$0-100.0%	$1.2M	$0	$0	$0+100.0%	-$113K-123.2%	-$50K+49.7%	-$100K
Net Income	-$153K+90.0%	-$1.5M-477.2%	-$263K+33.1%	-$394K-34.5%	-$293K+6.4%	-$313K-97.6%	-$158K+46.9%	-$298K
EPS (Diluted)	$-0.06	N/A	$-0.10+28.6%	$-0.14-27.3%	$-0.11	N/A	$-0.06+50.0%	$-0.12

LCTC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$6.7M-23.4%	$8.7M+0.4%	$8.7M+2.0%	$8.5M-4.8%	$8.9M+4.8%	$8.5M
Current Assets	$4.3M-16.2%	$5.1M-10.8%	$5.7M-2.9%	$5.9M+0.3%	$5.9M+6.2%	$5.5M
Cash & Equivalents	$746K-40.0%	$1.2M-29.6%	$1.8M-24.9%	$2.4M-8.5%	$2.6M+17.2%	$2.2M
Inventory	$2.6M-12.1%	$3.0M-0.9%	$3.0M+10.7%	$2.7M+2.4%	$2.7M+6.8%	$2.5M
Accounts Receivable	$772K+5.4%	$733K-9.8%	$812K+29.3%	$628K+11.7%	$562K+7.4%	$524K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.6M+3.4%	$2.5M+7.2%	$2.3M-1.3%	$2.4M+0.3%	$2.4M-10.6%	$2.6M
Current Liabilities	$837K+12.5%	$744K-35.3%	$1.1M+1.1%	$1.1M+5.0%	$1.1M-20.1%	$1.4M
Long-Term Debt	$1.1M-5.4%	$1.1M-4.4%	$1.2M-4.1%	$1.2M-3.8%	$1.3M-0.8%	$1.3M
Total Equity	$4.1M-34.1%	$6.2M-2.1%	$6.4M+3.3%	$6.2M-6.7%	$6.6M+11.7%	$5.9M
Retained Earnings	-$1.8M-386.1%	$640K-62.2%	$1.7M+13.8%	$1.5M-23.5%	$1.9M+53.4%	$1.3M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$6.7M+0.8%	$6.7M-19.5%	$8.3M-3.7%	$8.6M-6.5%	$9.2M+5.7%	$8.7M+4.6%	$8.3M+4.1%	$8.0M
Current Assets	$4.4M+2.4%	$4.3M-7.4%	$4.6M-7.2%	$5.0M-12.5%	$5.7M+11.4%	$5.1M+6.9%	$4.8M+5.5%	$4.5M
Cash & Equivalents	$569K-23.7%	$746K+8.9%	$685K-31.2%	$996K-34.6%	$1.5M+22.4%	$1.2M+47.8%	$842K+66.8%	$505K
Inventory	$2.8M+6.1%	$2.6M-8.0%	$2.9M-4.2%	$3.0M+1.6%	$2.9M-1.8%	$3.0M-5.2%	$3.2M+6.7%	$3.0M
Accounts Receivable	$850K+10.1%	$772K-10.7%	$864K+12.9%	$766K+0.5%	$762K+4.0%	$733K+19.8%	$611K-26.5%	$832K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.8M+7.9%	$2.6M-3.5%	$2.7M-2.1%	$2.7M-6.9%	$2.9M+17.6%	$2.5M+29.9%	$1.9M-13.8%	$2.2M
Current Liabilities	$1.1M+27.2%	$837K-7.8%	$908K-5.0%	$956K-15.7%	$1.1M+52.4%	$744K-5.1%	$784K-27.5%	$1.1M
Long-Term Debt	$1.0M-1.3%	$1.1M-1.3%	$1.1M-1.3%	$1.1M-1.2%	$1.1M-1.7%	$1.1M-1.1%	$1.1M-1.1%	$1.1M
Total Equity	$4.0M-3.7%	$4.1M-27.0%	$5.6M-4.5%	$5.9M-6.3%	$6.3M+0.9%	$6.2M-3.0%	$6.4M+11.1%	$5.8M
Retained Earnings	-$2.0M-8.3%	-$1.8M-490.7%	-$310K-567.0%	-$46K-113.4%	$347K-45.7%	$640K-32.8%	$953K-14.3%	$1.1M

LCTC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$499K+62.4%	-$1.3M-152.5%	-$526K-1067.8%	$54K-70.3%	$183K+113.4%	-$1.4M
Capital Expenditures	$463K-14.3%	$540K+7824.4%	$7K-96.8%	$213K-19.8%	$266K+867.6%	$27K
Free Cash Flow	-$962K+48.5%	-$1.9M-250.7%	-$533K-235.2%	-$159K-91.6%	-$83K+94.0%	-$1.4M
Investing Cash Flow	-$354K+48.6%	-$689K-8292.5%	-$8K+96.3%	-$223K+17.1%	-$268K-480.2%	-$46K
Financing Cash Flow	$356K-76.2%	$1.5M+2963.8%	-$52K-3.0%	-$51K-111.0%	$462K+10.3%	$419K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$129K-263.5%	$79K+141.9%	-$189K+34.7%	-$289K-188.2%	-$100K+65.6%	-$292K+7.0%	-$314K-288.8%	-$81K
Capital Expenditures	$5K-98.7%	$423K+2434.6%	$17K-26.8%	$23K	$0-100.0%	$62K-70.9%	$214K+4.0%	$206K
Free Cash Flow	-$135K+60.9%	-$344K-67.4%	-$206K+34.1%	-$312K-210.9%	-$100K+71.6%	-$354K+32.9%	-$527K-84.3%	-$286K
Investing Cash Flow	-$20K-368.2%	-$4K+96.1%	-$108K+51.8%	-$224K-1106.1%	-$19K+56.4%	-$43K+68.3%	-$134K+69.1%	-$433K
Financing Cash Flow	-$28K-96.8%	-$14K-0.7%	-$14K-0.7%	-$14K-103.5%	$398K-46.0%	$736K-6.1%	$785K+5961.6%	-$13K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

LCTC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	40.4%0.0pp	40.4%-2.9pp	43.3%+7.1pp	36.3%-7.1pp	43.4%+9.1pp	34.3%
Operating Margin	-13.6%+2.9pp	-16.5%-14.4pp	-2.1%+5.6pp	-7.7%-3.9pp	-3.8%+14.4pp	-18.2%
Net Margin	-27.4%-15.0pp	-12.3%-14.5pp	2.2%+7.6pp	-5.4%-14.9pp	9.6%+24.1pp	-14.5%
Return on Equity	-60.2%-43.3pp	-16.9%-20.1pp	3.2%+10.6pp	-7.4%-17.6pp	10.3%+25.9pp	-15.6%
Return on Assets	-37.0%-24.9pp	-12.1%-14.4pp	2.4%+7.7pp	-5.3%-12.9pp	7.5%+18.4pp	-10.8%
Current Ratio	5.10-1.7	6.85+1.9	4.97-0.2	5.17-0.2	5.42+1.3	4.07
Debt-to-Equity	0.26+0.1	0.180.0	0.18-0.0	0.200.0	0.19-0.0	0.22
FCF Margin	-10.7%+11.2pp	-21.9%-16.2pp	-5.7%-3.8pp	-1.9%-0.7pp	-1.2%+20.7pp	-21.9%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	43.0%+3.3pp	39.7%-0.5pp	40.2%-1.5pp	41.7%+1.8pp	39.9%+3.0pp	36.9%-6.8pp	43.7%+2.1pp	41.6%
Operating Margin	-5.6%+9.2pp	-14.8%-4.4pp	-10.4%+6.7pp	-17.0%-4.7pp	-12.3%+9.8pp	-22.1%-12.2pp	-10.0%+6.7pp	-16.6%
Net Margin	-6.7%+60.2pp	-66.9%-55.2pp	-11.7%+6.1pp	-17.7%-4.9pp	-12.8%+3.5pp	-16.4%-8.8pp	-7.6%+4.9pp	-12.5%
Return on Equity	-3.9%+33.2pp	-37.1%-32.4pp	-4.7%+2.0pp	-6.7%-2.0pp	-4.7%+0.4pp	-5.0%-2.6pp	-2.5%+2.7pp	-5.2%
Return on Assets	-2.3%+20.5pp	-22.7%-19.6pp	-3.2%+1.4pp	-4.6%-1.4pp	-3.2%+0.4pp	-3.6%-1.7pp	-1.9%+1.8pp	-3.7%
Current Ratio	4.11-1.0	5.10+0.0	5.08-0.1	5.19+0.2	5.01-1.8	6.85+0.8	6.08+1.9	4.17
Debt-to-Equity	0.260.0	0.26+0.1	0.190.0	0.180.0	0.180.0	0.180.0	0.18-0.0	0.20
FCF Margin	-5.9%+9.3pp	-15.1%-6.0pp	-9.1%+5.0pp	-14.1%-9.7pp	-4.4%+14.1pp	-18.5%+6.7pp	-25.3%-13.3pp	-12.0%

Similar Companies

Scientific Ind SCND

$9.1M

Global Warm GWSO

$11.5M

Nanalysis Sci NSCIF

$13.5M

Eddy Smart Home ESHSF

$6.1M

Darkpulse DPLS

$2.2M

Frequently Asked Questions

What is Lifeloc Technologies Inc's annual revenue?

Lifeloc Technologies Inc (LCTC) reported $9.0M in total revenue for fiscal year 2025. This represents a 5.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Lifeloc Technologies Inc's revenue growing?

Lifeloc Technologies Inc (LCTC) revenue grew by 5.7% year-over-year, from $8.5M to $9.0M in fiscal year 2025.

Is Lifeloc Technologies Inc profitable?

No, Lifeloc Technologies Inc (LCTC) reported a net income of -$2.5M in fiscal year 2025, with a net profit margin of -27.4%.

What is Lifeloc Technologies Inc's EBITDA?

Lifeloc Technologies Inc (LCTC) had EBITDA of -$787K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Lifeloc Technologies Inc have?

As of fiscal year 2025, Lifeloc Technologies Inc (LCTC) had $746K in cash and equivalents against $1.1M in long-term debt.

What is Lifeloc Technologies Inc's gross margin?

Lifeloc Technologies Inc (LCTC) had a gross margin of 40.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Lifeloc Technologies Inc's operating margin?

Lifeloc Technologies Inc (LCTC) had an operating margin of -13.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Lifeloc Technologies Inc's net profit margin?

Lifeloc Technologies Inc (LCTC) had a net profit margin of -27.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Lifeloc Technologies Inc's return on equity (ROE)?

Lifeloc Technologies Inc (LCTC) has a return on equity of -60.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Lifeloc Technologies Inc's free cash flow?

Lifeloc Technologies Inc (LCTC) generated -$962K in free cash flow during fiscal year 2025. This represents a 48.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Lifeloc Technologies Inc's operating cash flow?

Lifeloc Technologies Inc (LCTC) generated -$499K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Lifeloc Technologies Inc's total assets?

Lifeloc Technologies Inc (LCTC) had $6.7M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Lifeloc Technologies Inc's capital expenditures?

Lifeloc Technologies Inc (LCTC) invested $463K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Lifeloc Technologies Inc spend on research and development?

Lifeloc Technologies Inc (LCTC) invested $2.2M in research and development during fiscal year 2025.

How many shares does Lifeloc Technologies Inc have outstanding?

Lifeloc Technologies Inc (LCTC) had 3M shares outstanding as of fiscal year 2025.

What is Lifeloc Technologies Inc's current ratio?

Lifeloc Technologies Inc (LCTC) had a current ratio of 5.10 as of fiscal year 2025, which is generally considered healthy.

What is Lifeloc Technologies Inc's debt-to-equity ratio?

Lifeloc Technologies Inc (LCTC) had a debt-to-equity ratio of 0.26 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Lifeloc Technologies Inc's return on assets (ROA)?

Lifeloc Technologies Inc (LCTC) had a return on assets of -37.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Lifeloc Technologies Inc's cash runway?

Based on fiscal year 2025 data, Lifeloc Technologies Inc (LCTC) had $746K in cash against an annual operating cash burn of $499K. This gives an estimated cash runway of approximately 18 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Lifeloc Technologies Inc's Piotroski F-Score?

Lifeloc Technologies Inc (LCTC) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Lifeloc Technologies Inc's earnings high quality?

Lifeloc Technologies Inc (LCTC) has an earnings quality ratio of 0.20x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Lifeloc Technologies Inc cover its interest payments?

Lifeloc Technologies Inc (LCTC) has an interest coverage ratio of -10.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Lifeloc Technologies Inc?

Lifeloc Technologies Inc (LCTC) scores 38 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.